Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

501 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy.
Cerro-Herreros E, González-Martínez I, Moreno N, Espinosa-Espinosa J, Fernández-Costa JM, Colom-Rodrigo A, Overby SJ, Seoane-Miraz D, Poyatos-García J, Vilchez JJ, López de Munain A, Varela MA, Wood MJ, Pérez-Alonso M, Llamusí B, Artero R. Cerro-Herreros E, et al. Among authors: moreno n. Mol Ther Nucleic Acids. 2021 Jul 29;26:174-191. doi: 10.1016/j.omtn.2021.07.017. eCollection 2021 Dec 3. Mol Ther Nucleic Acids. 2021. PMID: 34513303 Free PMC article.
BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSALR Mice.
Overby SJ, Cerro-Herreros E, Espinosa-Espinosa J, González-Martínez I, Moreno N, Fernández-Costa JM, Balaguer-Trias J, Ramón-Azcón J, Pérez-Alonso M, Møller T, Llamusí B, Artero R. Overby SJ, et al. Among authors: moreno n. Pharmaceutics. 2023 Mar 31;15(4):1118. doi: 10.3390/pharmaceutics15041118. Pharmaceutics. 2023. PMID: 37111604 Free PMC article.
Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by promoting endogenous MBNL1 expression.
González-Martínez I, Cerro-Herreros E, Moreno N, García-Rey A, Espinosa-Espinosa J, Carrascosa-Sàez M, Piqueras-Losilla D, Arzumanov A, Seoane-Miraz D, Jad Y, Raz R, Wood MJ, Varela MA, Llamusí B, Artero R. González-Martínez I, et al. Among authors: moreno n. Mol Ther Nucleic Acids. 2023 Sep 5;34:102024. doi: 10.1016/j.omtn.2023.09.001. eCollection 2023 Dec 12. Mol Ther Nucleic Acids. 2023. PMID: 37744174 Free PMC article.
Basic Science and Pathogenesis.
Gutierrez BA, Moreno N, Keene CD, Limon A. Gutierrez BA, et al. Among authors: moreno n. Alzheimers Dement. 2024 Dec;20 Suppl 1:e093208. doi: 10.1002/alz.093208. Alzheimers Dement. 2024. PMID: 39751259
Nose-to-Brain Delivery of Biomimetic Nanoparticles for Glioblastoma Targeted Therapy.
Ferreira NN, Leite CM, Moreno NS, Miranda RR, Pincela Lins PM, Rodero CF, de Oliveira Junior E, Lima EM, Reis RM, Zucolotto V. Ferreira NN, et al. Among authors: moreno ns. ACS Appl Mater Interfaces. 2024 Dec 18. doi: 10.1021/acsami.4c16837. Online ahead of print. ACS Appl Mater Interfaces. 2024. PMID: 39692595
501 results